Literature DB >> 2549737

Cytomegalovirus encephalitis: neuropathological comparison of the guinea pig model with the opportunistic infection in AIDS.

J Booss1, J H Kim.   

Abstract

The AIDS epidemic has transformed the importance of cytomegalovirus (CMV) as a pathogen for the adult human central nervous system (CNS). At autopsy, about 25 percent of AIDS cases have cytopathologic evidence of CNS infection by CMV. Since almost nothing is known of the host CNS-viral interactions, we have developed a laboratory model of CMV infection of the brain in the guinea pig. In the present paper, we review the syndromes of CMV infection of the human CNS and compare the neuropathological findings of the opportunistic CMV brain infection in AIDS with the model. Destructive meningoencephalitis, perivascular infiltrates, and subependymal inflammation are found in both, but the glial nodule is the most characteristic feature of each. Thus, we demonstrate that the model faithfully reflects the histopathology of the human disease. Furthermore, since we have found that CNS infection is achieved following systemic infection in the guinea pig, the model recapitulates the sequence of infection in humans.

Entities:  

Mesh:

Year:  1989        PMID: 2549737      PMCID: PMC2589229     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  29 in total

1.  Virologic and clinical observations on cytomegalic inclusion disease.

Authors:  T H WELLER; J B HANSHAW
Journal:  N Engl J Med       Date:  1962-06-14       Impact factor: 91.245

2.  Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.

Authors:  R L Simmons; A J Matas; L C Rattazzi; H H Balfour; J R Howard; J S Najarian
Journal:  Surgery       Date:  1977-11       Impact factor: 3.982

3.  Cytomegalovirus encephalitis in adults.

Authors:  L J Dorfman
Journal:  Neurology       Date:  1973-02       Impact factor: 9.910

4.  Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions.

Authors:  W P Carney; M S Hirsch
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

5.  Central nervous system vasculitis in cytomegalovirus infection.

Authors:  A H Koeppen; L S Lansing; S K Peng; R S Smith
Journal:  J Neurol Sci       Date:  1981-09       Impact factor: 3.181

6.  Cytomegalovirus encephalitis in a noncompromised host.

Authors:  Y Siegman-Igra; D Michaeli; A Doron; M Weinberg; Y D Heilbroun
Journal:  Isr J Med Sci       Date:  1984-02

7.  Cytomegalovirus encephalitis in immunologically normal adults. Successful treatment with vidarabine.

Authors:  C A Phillips; W L Fanning; D W Gump; C F Phillips
Journal:  JAMA       Date:  1977-11-21       Impact factor: 56.272

8.  School failure and deafness after "silent" congenital cytomegalovirus infection.

Authors:  J B Hanshaw; A P Scheiner; A W Moxley; L Gaev; V Abel; B Scheiner
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

9.  Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.

Authors:  W D Snider; D M Simpson; S Nielsen; J W Gold; C E Metroka; J B Posner
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

10.  Cytomegaloviral infections in the guinea pig: experimental models for human disease.

Authors:  F J Bia; B P Griffith; C K Fong; G D Hsiung
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr
View more
  1 in total

1.  Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

Authors:  J Neyts; H Sobis; R Snoeck; M Vandeputte; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.